Radiology Case Reports (May 2024)

Radiological impact of oral bisphosphonate use on polyostotic Paget's disease of bone over a 2 year period

  • Christopher Jude Pinto, MD,
  • Shadab B. Maldar, MD,
  • Siddhi Hegde, MD,
  • Sharanabasav M. Choukimath, MD

Journal volume & issue
Vol. 19, no. 5
pp. 1886 – 1892

Abstract

Read online

Paget's disease of bone is a disorder of osteoclasts which hampers the physiological process of bone remodeling. It is the most common metabolic orthopedic disease in the Caucasian populace; we report the diagnosis of Paget's disease of bone in a South-Asian male in his early 50s with a history of gastrointestinal symptoms, weight loss and back pain. An alkaline phosphatase level of 1104 IU/L was noted. A 3-phase bone scan showed noncontiguous heterogenous nuclear uptake. After exhaustive evaluation, the patient was diagnosed with Paget's disease of bone. Despite the disease activity being mitigated by alendronate and monitored by ALP levels within normal range per protocol, the patient had compression fractures of the vertebrae requiring early reinitiation of oral bisphosphonates. This raised doubts about the efficacy of metabolic marker-based management in Paget's disease of bone.

Keywords